139 related articles for article (PubMed ID: 35865381)
1. Short-Term Prognostic Efficacy of mGPS and LCS in Patients With Acute Heart Failure.
Wang J; Xie L; Lyu P; Zhou F; Cai HL; Qi RX; Zhang Q
Front Cardiovasc Med; 2022; 9():944424. PubMed ID: 35865381
[TBL] [Abstract][Full Text] [Related]
2. Prognostic efficacy of preoperative mGPS, SIS and LCS in patients with gastric cancer.
Chen YR; Chen YL; Ouyang SS; Xu HW; Li P; He LJ; Zhu SL
Clin Chim Acta; 2020 Dec; 511():81-89. PubMed ID: 33002476
[TBL] [Abstract][Full Text] [Related]
3. Modified Glasgow Prognostic Score is a novel predictor of clinical outcome in heart failure with preserved ejection fraction.
Bolat I; Biteker M
Scand Cardiovasc J; 2020 Jun; 54(3):174-178. PubMed ID: 31965867
[No Abstract] [Full Text] [Related]
4. Predictive value of three Inflammation-based Glasgow Prognostic Scores for major cardiovascular adverse events in patients with acute myocardial infarction during hospitalization: a retrospective study.
Zhu H; Li Z; Xu X; Fang X; Chen T; Huang J
PeerJ; 2020; 8():e9068. PubMed ID: 32355581
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems.
Lamb GW; Aitchison M; Ramsey S; Housley SL; McMillan DC
Br J Cancer; 2012 Jan; 106(2):279-83. PubMed ID: 22166802
[TBL] [Abstract][Full Text] [Related]
6. The inflammation-based modified Glasgow prognostic score is associated with survival in stable heart failure patients.
Cho A; Arfsten H; Goliasch G; Bartko PE; Wurm R; Strunk G; Hülsmann M; Pavo N
ESC Heart Fail; 2020 Apr; 7(2):654-662. PubMed ID: 32096921
[TBL] [Abstract][Full Text] [Related]
7. Modified Glasgow Prognostic Score, Prognostic Nutritional Index and ECOG Performance Score Predicts Survival Better than Sarcopenia, Cachexia and Some Inflammatory Indices in Metastatic Gastric Cancer.
Demirelli B; Babacan NA; Ercelep Ö; Öztürk MA; Kaya S; Tanrıkulu E; Khalil S; Hasanov R; Alan Ö; Telli TA; Koca S; Arıbal ME; Kuzan B; Dane F; Yumuk PF
Nutr Cancer; 2021; 73(2):230-238. PubMed ID: 32270713
[No Abstract] [Full Text] [Related]
8. Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
Higgins MI; Martini DJ; Patil DH; Nabavizadeh R; Steele S; Williams M; Joshi SS; Narayan VM; Sekhar A; Psutka SP; Ogan K; Bilen MA; Master VA
Cancer; 2021 Jun; 127(12):1974-1983. PubMed ID: 33760232
[TBL] [Abstract][Full Text] [Related]
9. Modified Glasgow Prognostic Score is Better for Predicting Oncological Outcome in Patients with Soft Tissue Sarcoma, Compared to High-Sensitivity Modified Glasgow Prognostic Score.
Nakamura T; Asanuma K; Hagi T; Sudo A
J Inflamm Res; 2022; 15():3891-3899. PubMed ID: 35845092
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer.
Wang F; He W; Jiang C; Guo G; Ke B; Dai Q; Long J; Xia L
BMC Cancer; 2018 Nov; 18(1):1102. PubMed ID: 30419863
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study.
Kasahara K; Enomoto M; Udo R; Tago T; Mazaki J; Ishizaki T; Yamada T; Nagakawa Y; Katsumata K; Tsuchida A
BMC Cancer; 2022 Jan; 22(1):20. PubMed ID: 34980009
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma.
Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
J Gastroenterol; 2016 Feb; 51(2):153-61. PubMed ID: 26187429
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Inflammation Biomarkers for Survival of Patients with Neuroblastoma.
Zheng C; Liu S; Feng J; Zhao X
Cancer Manag Res; 2020; 12():2415-2425. PubMed ID: 32280277
[TBL] [Abstract][Full Text] [Related]
14. The combination of hand grip strength and modified Glasgow prognostic score predicts clinical outcomes in patients with liver cancer.
Chen Y; Ruan GT; Shi JY; Liu T; Liu CA; Xie HL; Song MM; Wang ZW; Hu CL; Zhang HY; Zhang XW; Tian HY; Ge YZ; Yang M; Liu YY; Lin SQ; Liu XY; Zheng X; Wang KH; Cong MH; Shen X; Wang X; Deng L; Shi HP
Front Nutr; 2023; 10():1062117. PubMed ID: 36923698
[TBL] [Abstract][Full Text] [Related]
15. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.
Xiao Y; Ren YK; Cheng HJ; Wang L; Luo SX
Int J Clin Exp Pathol; 2015; 8(5):5273-81. PubMed ID: 26191228
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer.
Guthrie GJ; Roxburgh CS; Farhan-Alanie OM; Horgan PG; McMillan DC
Br J Cancer; 2013 Jul; 109(1):24-8. PubMed ID: 23799846
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment Glasgow prognostic score and prognostic nutritional index predict overall survival of patients with advanced small cell lung cancer.
Minami S; Ogata Y; Ihara S; Yamamoto S; Komuta K
Lung Cancer (Auckl); 2017; 8():249-257. PubMed ID: 29263709
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
[TBL] [Abstract][Full Text] [Related]
19. Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score.
Hirahara N; Matsubara T; Kaji S; Kawabata Y; Hyakudomi R; Yamamoto T; Uchida Y; Ishitobi K; Takai K; Tajima Y
Oncotarget; 2020 Nov; 11(45):4169-4177. PubMed ID: 33227100
[TBL] [Abstract][Full Text] [Related]
20. Appraisal of inflammation-based prognostic scores in patients with unresectable perihilar cholangiocarcinoma.
Okuno M; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Yamaguchi J; Nagino M
J Hepatobiliary Pancreat Sci; 2016 Oct; 23(10):636-642. PubMed ID: 27474781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
